Craig R. Stapleton, Director at AVADEL PHARMACEUTICALS PLC (AVDL), bought 70,000 shares at $8.67 ($607K) on 2017-12-15, disclosed to the SEC on 2017-12-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| AVDL | BUY | 2017-05-22 | $110K | — | Filing → |
| AVDL | BUY | 2017-05-22 | $305K | — | Filing → |
| FLML | BUY | 2016-11-30 | $216K | — | Filing → |